A clinically-validated digital cognitive assessment for healthcare providers, researchers, and individuals.
10 minutes · Instant results · Optional personal account to track changes over time
Boston Cognitive Assessment (BoCA™) is a scientifically validated, self-administered digital cognitive assessment designed for clinical, research, and personal use.
Complete in under 10 minutes, BoCA™ evaluates cognitive performance across eight domains using randomized, non-repeating tasks—minimizing practice effects and supporting reliable longitudinal tracking. As an online, automatically scored tool, BoCA™ is used by researchers for serial assessment of global cognition in clinical trials studying Alzheimer's, COVID fog, anesthesia, and cancer treatment.
BoCA™ evaluates eight key cognitive domains using scientifically validated tasks.
Immediate and delayed recall of verbal and visual information
Sustained, selective, and divided attention tasks
Naming, comprehension, and verbal fluency
Planning, set-shifting, and problem-solving
Arithmetic reasoning and calculation
Spatial perception and constructional praxis
Temporal and spatial orientation
Delayed retrieval of previously presented information
BoCA™ offers significant advantages over traditional pen and paper cognitive testing tools, providing comprehensive assessment with modern digital capabilities.
| MMSE, Mini-Cog | BoCA™ | |
|---|---|---|
| Brief, under 10 minutes | ✓ | ✓ |
| Cost Effective | ✓ | ✓ |
| Clinically Validated | ✓ | ✓ |
| Reimbursable* | ✗ | ✓ |
| Self-administered by Patient | ✗ | ✓ |
| Longitudinal Results | ✗ | ✓ |
| Provides normal ranges for age & sex | ✗ | ✓ |
| Randomized to avoid learning effect | ✗ | ✓ |
| Evaluates 8 domains of cognitive function | ✗ | ✓ |
| Multi-language support | ✗ | ✓ |
*Restrictions apply. Visit Boston Cognitive Platform Help Center for more information.
The BoCA™ has been validated in several key peer-reviewed studies that establish its reliability and correlation with "gold standard" cognitive assessments like the Montreal Cognitive Assessment (MoCA).
Vyshedskiy A, et al. BMC Neurology, 2022.
Key findings: Primary validation paper. Strong correlation with MoCA (R = 0.90), excellent test-retest reliability, and insignificant practice effects over 10 consecutive days of testing.
View study →Padovani A, Caratozzolo S, Galli A, et al. Neurological Sciences, 2024.
Key findings: Strong convergent validity with MoCA across the Alzheimer's disease spectrum in an Italian population. Confirmed BoCA's ability to differentiate between cognitive impairment levels internationally.
View study →Thompson LI, et al. Alzheimer's & Dementia, 2025.
Key findings: BoCA is feasible and well-accepted by older adults in primary care settings. Digital cognitive screening can be successfully implemented in real-world clinical environments with high patient acceptability.
View study →Gold D, et al. The Clinical Neuropsychologist, 2021.
Key findings: Established BoCA's psychometric foundations, validating its internal structure and reliability for use in diverse populations without direct supervision.
View study →Ferguson H, et al. Archives of Clinical Neuropsychology, 2022.
Key findings: Analyzed how age and education levels influence BoCA performance, providing normative data for score interpretation across demographic groups.
View study →Wertheimer J, et al. Archives of Physical Medicine and Rehabilitation, 2025.
Key findings: Demonstrated BoCA's reliability for assessing cognitive function in acute rehabilitation settings, supporting its use across diverse clinical environments.
View study →Yin X, Zhu H, Ji P, Zhang Y, Wu B. Frontiers in Neurology, 2025.
Key findings: Validated BoCA's effectiveness for evaluating and monitoring cognitive deficits in stroke survivors, expanding its clinical utility to neurological rehabilitation.
View study →Read more about our evidence-based approach to brain health on the Boston Cognitive validation page.
BoCA™ is designed to support healthcare providers in delivering efficient, scalable, and evidence-informed cognitive care. From early detection to ongoing monitoring, BoCA™ enables self-administered testing in clinical or remote settings—with results mapped to key cognitive domains like memory, attention, and executive function. It fits seamlessly into CPT-aligned workflows, supporting reimbursable care delivery without requiring extra time or staffing.
Discover how BoCA integrates with Boston Cognitive's care planning, analytics, and patient engagement tools.
Longitudinal monitoring is essential for testing novel interventions designed to reduce or reverse cognitive aging. BoCA™ is an invaluable tool for long-term cognitive monitoring. As an online instrument, BoCA™ evaluates global cognition through tasks spanning eight domains commonly included in other familiar screening instruments (e.g., wordlist learning and delayed recall, repeating numerical sequences forward and backward, executive functioning, mental arithmetic, visuospatial reasoning, language, and orientation).
BoCA™ uses randomly generated, non-repeating stimuli when assessing each domain, enhancing its utility for serial assessment and long-term monitoring of cognitive status. It is automatically scored and designed to reduce the risks of practice effects, making it especially beneficial for research projects requiring cognitive tracking.
BoCA™ is currently utilized in dozens of clinical trials studying the effects of cognitive interventions, pharmaceutical treatments for Alzheimer's disease, COVID fog, anesthesia and preoperative treatment, long-term effects of cancer drugs, and other interventional studies of Alzheimer's disease and dementia.
Interested in the science behind our tools? Visit our research resources page to explore peer-reviewed publications on dementia prevention, cognitive assessment validation, and lifestyle interventions.
BoCA™ lets you check in on your cognitive function—anytime, from anywhere. This 10-minute, self-guided test helps you understand how your brain is working across key areas like memory, attention, and executive function.
Whether you're proactively monitoring your brain health or simply curious, BoCA gives you fast, research-based insight you can trust.
Complete your first assessment to create a free personal account and track your cognitive health over time.
Prefer using an app?
Get in touch with our team for questions about BoCA™, enterprise solutions, or technical support.
By submitting, you agree to receive emails from Boston Cognitive. You can unsubscribe anytime.
Disclaimer: Boston Cognitive tools are designed to support cognitive health monitoring and lifestyle modification. They are not intended to diagnose, treat, cure, or prevent any disease. Our assessments and programs do not provide medical advice, therapy, or clinical diagnosis. Always consult with a qualified healthcare provider.